Stay updated on Sitravatinib Combo Clinical Trial

Sign up to get notified when there's something new on the Sitravatinib Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sitravatinib Combo Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2; the study record remains unavailable on this page.
    Difference
    1%
    Check dated 2026-10-20T22:11:37.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-06T22:03:46.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record. Consequently, the study details and related sections are no longer visible and are replaced by the error page content.
    Difference
    18%
    Check dated 2026-09-22T23:10:10.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.7.0, replacing the previous v3.6.6 and indicating an updated version of the study documentation.
    Difference
    0.1%
    Check dated 2026-09-15T21:47:31.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, signaling a small metadata update to the study record.
    Difference
    0.1%
    Check dated 2026-09-01T17:46:26.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Results were posted on 2026-08-04 for the study, adding a 'Results Posted' section with safety and outcome details, including the number of participants with treatment-related adverse events, treatment discontinuations due to AEs, and clinically significant laboratory abnormalities, along with the associated results dates and documents. The previous result measures such as 'Frequency of subjects experiencing treatment-related AEs' and 'Time to clinical or radiographic progression' were removed.
    Difference
    2%
    Check dated 2026-08-11T16:10:58.000Z thumbnail image

Stay in the know with updates to Sitravatinib Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo Clinical Trial page.